Health Cor Management, L.P. Bristol Myers Squibb CO Call Options Transaction History

Health Cor Management, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $8.55 Million - $10.1 Million	-200,000 Reduced 33.33%	400,000 $20.3 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $4.46 Million - $4.93 Million	100,000 Added 20.0%	600,000 $27.2 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $24.4 Million - $31.6 Million	500,000 New	500,000 $27.7 Million
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $27.6 Million - $31.1 Million	-500,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $25.3 Million - $31.5 Million	500,000 New	500,000 $27.7 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.